Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation

Anti-tumor necrosis factor alpha (TNF-α) antibodies are effective in patients with inflammatory bowel disease (IBD). However, the effect is not optimal because a sufficient concentration of antibodies cannot be maintained at the site of inflammation. Thus, a macromolecular complex was developed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakisaka, Hideto, Takedatsu, Hidetoshi, Mitsuyama, Keiichi, Mochizuki, Shinichi, Sakurai, Kazuo, Sakisaka, Shotaro, Hirai, Fumihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014273/
https://www.ncbi.nlm.nih.gov/pubmed/31968666
http://dx.doi.org/10.3390/ijms21020683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014273/
https://www.ncbi.nlm.nih.gov/pubmed/31968666
http://dx.doi.org/10.3390/ijms21020683

Ejemplares similares